Commercial Seed Market Updates

Global Commercial Seed Market size was valued at USD 73.5 billion in 2023 and is poised to grow from USD 78.87 billion in 2024 to USD 138.57 billion by 2032, growing at a CAGR of 7.3% during the forecast period (2025-2032). 

The worldwide commercial seed market appears fragmented, Because of the large number of participants. Players in corporate strategic efforts such as mergers and acquisitions, expansion, collaboration, and product/technology introduction seek to achieve a greater competitive share. 'Bayer AG (Germany) ', 'Corteva Agriscience (USA) ', 'Syngenta AG (Switzerland) ', 'BASF SE (Germany) ', 'Groupe Limagrain (Vilmorin & Cie) (France) ', 'KWS SAAT SE & Co. KGaA (Germany) ', 'DLF Seeds A/S (Denmark) ', 'Sakata Seed Corporation (Japan) ', 'Takii & Co., Ltd. (Japan) ', 'Land O'Lakes, Inc. (WinField United) (USA) ', 'Rijk Zwaan (Netherlands) ', 'Advanta Seeds (UPL Limited) (India) ', 'Bejo Zaden B.V. (Netherlands) ', 'Enza Zaden (Netherlands) ', 'East-West Seed (Thailand) ', 'Nufarm Limited (Australia) ', 'Rallis India Limited (India) ', 'China National Seed Group Corporation (China) ', 'Mahyco (Maharashtra Hybrid Seeds Company Limited) (India) ', 'DL Seeds (Canada) '

Population Growth Around the World:

Maize (corn) was predicted to have a market share of 40.2%. Corn is also used in animal feed, and demand for it is likely to rise as meat consumption rises, particularly in emerging nations. Furthermore, the widespread use of maize products in the production of starch and sweeteners is likely to drive category expansion throughout the projection period.

Based on region, North America currently dominates the global commercial seed market, accounting for about 32% of the total market share. Regional market growth is likely to be fueled by extensive R&D, favorable government policies, and the cost-effectiveness of commercial seeds. Seeders have gathered more detailed data as a result of the advent of precision farming. Farmers are expected to be more aware of these seeds as a result of this. Europe captured the second-largest share of the market, owing to an increase in individual demand for botox operations in key European nations and increased research and development spending in Europe.